Post-Conference Perspectives: Breast Cancer Recurrence Monitoring by ctDNA - Episode 2

Clinical Evidence Supporting the use of ctDNA to Detect Recurrence

A breast cancer expert provides a brief overview of clinical evidence supporting the use of ctDNA to detect recurrence.

EP. 1: Best Practices for Assessing Risk of Recurrence in Patients with Breast Cancer
Now Viewing
EP. 2: Clinical Evidence Supporting the use of ctDNA to Detect Recurrence
EP. 3: Data Review: ctDNA Monitoring in Patients with Breast Cancer
EP. 4: Practical Clinical Applications for ctDNA Assessment
EP. 5: Technical and Logistical Challenges Concerning the use of ctDNA Monitoring
EP. 6: Promising Strategies for Assessing Risk and Detecting Recurrence Earlier

Related Content:

Post-Conference Perspectives: Breast Cancer Recurrence Monitoring by ctDNAOncLive News Network®
Key Takeaways for Concurrent Biomarker Testing in NSCLC
Overcoming Barriers to NSCLC Biomarker Testing
Challenges of NSCLC Biomarker Testing in Clinical Practice